Traumatic brain injury (TBI) is the leading cause of death and disability in trauma patients,
and can be classified into mild, moderate, and severe by the Glasgow coma scale (GCS) …

The present article reviewed the pharmacologic therapies of traumatic brain injury (TBI),
including current and potential treatments. Pharmacologic therapies are an essential part of …

Background Severe traumatic injury continues to present challenges to healthcare systems
around the world, and post-traumatic bleeding remains a leading cause of potentially …

Background Severe trauma continues to represent a global public health issue and mortality
and morbidity in trauma patients remains substantial. A number of initiatives have aimed to …

Background Severe traumatic brain-injured (TBI) patients should be primarily admitted to a
hub trauma center (hospital with neurosurgical capabilities) to allow immediate delivery of …

Prognosis of the long-term functional outcome of traumatic brain injury is essential for
personalized management of that injury. Nonetheless, accurate prediction remains …

The acute phase management of patients with severe traumatic brain injury (TBI) and
polytrauma represents a major challenge. Guidelines for the care of these complex patients …

Emerging evidence suggests that biofluid-based biomarkers have diagnostic and prognostic
potential in traumatic brain injuries (TBI). However, owing to the lack of a conceptual …

OBJECTIVE To evaluate the rate of, reasons for, and predictors of unplanned reoperation
after craniotomy for tumor in a nationally accrued population. METHODS Patients who …

Coagulopathy is a known sequela of traumatic brain injury (TBI) and can lead to increased
morbidity and mortality. Platelet dysfunction has been identified as one of several etiologies …